Supply and delivery of small biological preparations to the department of health for the period 01 january 2028 to 31 december 2030

The National Industrial Participation (NIP) Programme applies to all government procurement contracts with imported content. The NIP obligation is benchmarked on the imported content of the contract. A NIP obligation arises when imported content equals or exceeds US$10 million, or when multiple contracts for the same goods/services each with imported content exceeding US$3 million are awarded to one seller over 2 years and total exceeds US$10 million. The obligation is 30% of the imported content, discharged over 7 years. Successful bidders with contracts exceeding R10 million must report to the DTI within 5 working days of award. The DTI will negotiate agreements such as investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing arrangements, and R&D to satisfy the obligation.

Closing date: 2 November 2026 at 11:00. Non-compulsory online briefing session: 18 September 2026 at 10:00 via MS Teams.

Bidding procedure and technical enquiries: [email protected]. Submission address: Directorate: Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, 0187.

Bids must be delivered to the Tender Box at the Directorate: Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, before the closing date and time. Late bids will not be accepted. All bids must be submitted on the official forms provided, not re-typed. Returnable documents include: SBD 1 (Invitation to Bid), SBD 4 (Declaration of Interest), SBD 6.1 (Preference Points Claim), SBD 5 (National Industrial Participation), PBD 8 (Declaration of Compliance with SRCC/GCC), PBD 11 (Declaration of Financial Solvency and Business Rescue Status), PBD 5 (GMP Declaration), PBD 1 (Authorisation Declaration if sourcing from a third party), PBD 3/PBD 3.1 (Bid Signature Authorisation), PBD 9.1/PBD 9.2 (Directors Profile), and proof of authority (e.g. company resolution). Failure to provide or comply with any required particulars may render the bid invalid.

The applicable preference point system is the 90/10 system. Maximum points: 90 for price, 10 for specific goals (B-BBEE Status Level of Contributor), total 100. Points for B-BBEE status: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, Non-compliant = 0. Bidders must submit a valid SANAS accredited B-BBEE certificate or a sworn affidavit for EME/QSE to claim preference points; failure to submit supporting evidence results in zero preference points but does not render the bid non-responsive.

Bidders must declare financial solvency and confirm they are not under business rescue, liquidation, sequestration, administration, or judicial management. They must undertake to notify the Department within 5 working days of any financial event that may materially affect performance. Successful bidders with contracts exceeding R10 million must report to the DTI within 5 working days of award. NIP obligations apply to contracts with imported content equal to or exceeding US$10 million; the obligation is 30% of imported content, discharged over 7 years.

Bidders must be registered on the Central Supplier Database (CSD) and provide a SARS Tax Compliance Status PIN or CSD number. Each party in a consortium/JV/sub-contractor arrangement must submit a separate TCS certificate/PIN/CSD number. Bids from persons in the service of the state, or companies/close corporations with directors/members in the service of the state, will not be considered. Bidders must complete and submit SBD 4 (Declaration of Interest), SBD 6.1 (Preference Points Claim), SBD 5 (National Industrial Participation), PBD 8 (compliance with SRCC/GCC), PBD 11 (financial solvency), PBD 5 (GMP declaration), and PBD 1 (authorisation declaration if sourcing from a third party).

The successful bidder will be required to fill in and sign a written contract form (SBD 7). The contract is subject to the General Conditions of Contract (GCC) and Special Requirements and Conditions of Contract (SRCC). Bidders must declare financial solvency and confirm they are not under business rescue, liquidation, sequestration, administration, or judicial management. They must undertake to notify the Department within 5 working days of any financial event that may materially affect performance. False declarations may result in disqualification, contract termination, reporting to National Treasury for restriction considerations, and/or further legal action.

The 90/10 preference point system applies. Maximum points: 90 for price, 10 for specific goals (B-BBEE Status Level of Contributor). Points for B-BBEE status: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, Non-compliant = 0. Bidders must submit a valid SANAS accredited B-BBEE certificate or a sworn affidavit for EME/QSE to claim preference points; failure to submit supporting evidence results in zero preference points but does not render the bid non-responsive.

Returnable form: PBD 9.1 (Directors Categorisation) — bidders must complete and submit this form listing all directors of the single bidding enterprise with full names, surname, nationality, identity or passport number, director appointment status (Y/N), executive or non-executive designation, and whether they hold ownership or directorship in any related enterprise (Y/N) with details if applicable. Bidders must also mark the legal structure of the enterprise (Close Corporation, Company, Incorporated Joint Venture, or Listed Company).

Bidders must be registered on the Central Supplier Database (CSD) and have no history of non-performance or fraud. For tenders exceeding R10 million, bidders must demonstrate a minimum B-BBEE level 4 contributor status. Local production and content requirements apply as specified in each tender document, with a minimum threshold of 70% for designated sectors. Joint ventures must submit a formal agreement outlining the division of work and responsibilities.

Cell G2: Ownership or Director in related enterprise/s whether or not such enterprise/s are bidding in this tender? (Y/N)

Returnable form: PBD 9.1 (Directors Categorisation) — bidders must complete and submit this form listing all directors of the single bidding enterprise with full names, surname, nationality, identity or passport number, director appointment status (Y/N), executive or non-executive designation, and whether they hold ownership or directorship in any related enterprise (Y/N) with details if applicable. Bidders must also mark the legal structure of the enterprise (Close Corporation, Company, Incorporated Joint Venture, or Listed Company).

{"closingDate":"01 JANUARY 2028"}

{"name":null,"email":null,"phone":null,"department":"OF HEALTH FOR THE PERIOD 01 JANUARY 2028 TO 31 DECEMBER 2030","address":"butor name Name of authorised distributor"}

No eligibility criteria specified

Invoice line items must include: EAN 13 item barcode; generic product description and brand name as per Contract Circular and Purchase Order; contract reference with addendum and item number (format Contract#_Addendum#_Item#, addendum two digits, item three digits); quantity ordered and quantity supplied per delivery; batch number and expiry date on separate lines when multiples exist; unit price (VAT inclusive) to four decimal places as per Contract Circular or addendum, including VAT and delivery; line total as unit price multiplied by delivered quantity. Summary totals: total excluding VAT, VAT amount, and grand total each to two decimal places. Proof of delivery requires: date received; printed name, PERSAL number and signature of receiver; number of cartons received; facility stamp space; GRV number; claim reference number if applicable.

Unit prices must be quoted VAT inclusive to four decimal places and must include delivery. Invoice totals must show amounts excluding VAT, VAT amount, and inclusive total, each to two decimal places. Invoices must reference a single Purchase Order number per invoice and include the Purchase Order barcode. Supplier must provide CSD registration number (MAAA), company registration number, and VAT number on every invoice.

Invoices must display supplier CSD registration number (MAAA), company registration number, VAT number, and NDoH Supplier Code as per the contract circular. Supplier logo, legal name, physical and postal addresses, and contact details for queries and debtors must appear. Distributor name must be shown where applicable. Deliver-to details must include facility name, demander code, Master Health Facility Number (MHFL), delivery address, and designated receiver per Purchase Order. Invoice header must state TAX INVOICE, COPY TAX INVOICE (Supplier Copy), or COPY TAX INVOICE (Customer Copy) as appropriate. Invoice number and date, page numbering, and 1D barcodes for invoice and Purchase Order numbers are required.

All invoices for products delivered under this contract must contain the following mandatory data fields: Invoice header — TAX INVOICE (original), COPY TAX INVOICE (Supplier Copy), or COPY TAX INVOICE (Customer Copy). Supplier information — logo, legal name, NDoH Supplier Code, CSD registration number (MAAA), company registration number, VAT number, and authorised distributor name. Supplier contact details — physical and postal addresses, queries telephone and email, debtors telephone and email. Deliver-to information — supplier account number, facility name, demander code, Master Health Facility Number (MHFL), delivery address, designated receiver name/rank, and facility contact number per Purchase Order. Invoice details — unique invoice number, 1D invoice barcode, invoice date, page numbering. Order details — single Purchase Order number per invoice with 1D barcode, order captured date, special instructions from Purchase Order. Invoice line information — EAN 13 item barcode, generic product description, brand name, contract/addendum/item reference, quantity ordered, quantity supplied, batch number (separate line per batch), expiry date (separate line per expiry), unit price VAT inclusive to four decimals including delivery, line total. Summary totals — total excluding VAT, VAT amount, grand total, each to two decimals. Invoice-to details — pay office name, address, VAT number, telephone per Purchase Order. Goods received / proof of delivery — date received, receiver printed name, PERSAL number, signature, cartons received, facility stamp space, GRV number, claim reference number if relevant.

{"name":null,"email":null,"phone":null,"department":null,"address":"or member."}

Preference points for specific goals are claimed under the Preferential Procurement Regulations, 2022. Bidders with annual turnover exceeding R50 million must submit a valid SANAS accredited B-BBEE certificate and may not submit an EME/QSE sworn affidavit. An incorrectly completed QSE/EME affidavit is invalid and preference points will not be allocated.

B-BBEE compliance: Bidders with annual turnover between R10 million and R50 million qualify as a Qualifying Small Enterprise (QSE); those with turnover below R10 million qualify as an Exempted Micro Enterprise (EME). Bidders with turnover above R50 million must submit a valid SANAS accredited B-BBEE certificate. QSE/EME bidders must submit a sworn affidavit completed in accordance with the guidance in Annexure C. The affidavit must include the deponent's name and ID number, designation (director, owner or member), enterprise name and address as per CIPC registration, percentage of black ownership, black female ownership and designated group ownership, total revenue for the year under review, basis of revenue (audited financial statements or management accounts), financial year end, B-BBEE status level, and empowering supplier status. The deponent's signature date and Commissioner of Oaths' signature date must correspond. The Commissioner of Oaths must not be an employee or ex officio of the enterprise. An incorrectly completed affidavit is invalid and preference points will not be allocated.

B-BBEE classification: QSE (turnover between R10 million and R50 million) and EME (turnover less than R10 million). Bidders with turnover exceeding R50 million must submit a valid SANAS accredited B-BBEE certificate and do not qualify for an EME/QSE sworn affidavit. The sworn affidavit must be completed correctly; otherwise preference points for specific goals will not be allocated. Key requirements for the affidavit: deponent's name and ID number; designation (director, owner or member); enterprise name and address as per CIPC registration; percentage of black ownership, black female ownership and designated group ownership; total revenue for the year under review and whether based on audited financial statements or management accounts; financial year end; B-BBEE status level (only one status level); empowering supplier status; signature dates of deponent and Commissioner of Oaths must correspond; Commissioner of Oaths must not be an employee or ex officio of the enterprise.

Preference points for specific goals are claimed under the Preferential Procurement Regulations, 2022. An incorrectly completed QSE/EME affidavit is invalid and preference points will not be allocated.

Closing date: 2 November 2026 at 11:00 am. Briefing session: non-compulsory online briefing via MS Teams on 18 September 2026 at 10H00. The bid document will be published on the website on 4 September 2026.

All inquiries must be emailed to [email protected].

Bids must be delivered to the DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143. The bid document is obtainable from the Department of Health website (www.health.gov.za) and the e-tender portal on the National Treasury website; bidders must click on the 'TENDERS' tab and then the 'PHARMACEUTICAL TENDERS' tab to download it. All enquiries must be emailed to [email protected]. Submission hours are 07h30 to 15h30.

The bid will be evaluated in four phases: Phase I – compliance with mandatory administrative bid requirements; Phase II – compliance with product, technical and legal mandatory requirements; Phase III – compliance with B-BBEE requirements as per Section 9 of the Special Requirements and Conditions of Contract (SRCC); Phase IV – recommendation and award.

Bidders must comply with mandatory administrative bid requirements (Phase I) and product, technical and legal mandatory requirements (Phase II). Bidders must comply with B-BBEE requirements as per Section 9 of the SRCC (Phase III).

Evaluation is conducted in four phases: administrative compliance, product/technical/legal compliance, B-BBEE compliance per Section 9 of the SRCC, and recommendation/award.

The tender is for the supply and delivery of small biological preparations to the Department of Health for the period 01 January 2028 to 31 December 2030. Bidders must note that status relating to tax, licence to manufacture, certificates, etc., must be provided.

Bidders must submit all documents in the exact order listed in the bid document index. Each document must be sorted, filed, and submitted as specified. If a document is not applicable, the bidder must explicitly indicate "N/A" and provide justification; blacking out the N/A field is not acceptable. The signed Excel Bid Response (Pricing Schedule) is mandatory; if not signed, the bid will not be considered for evaluation. A digital copy of the completed bid must be provided on a USB flash drive, with each document saved as a separate file named using the admin code abbreviations. Returnable forms include: PBD3 (Bid Signature Authorisation), SBD1 (Invitation to Bid), SBD4 (Declaration of Interest), SBD6.1 (Preference Points Claim), SBD5 (National Industrial Participation Programme), PBD11 (Declaration of Financial Solvency and Business Rescue Status), PBD5 (GMP Declaration of Compliance), PBD8 (SRCC and GCC Declaration of Compliance), and the signed pricing schedule. Bidders must initial every page of the SRCC and GCC.

Bidders must be registered on the Central Supplier Database (CSD) and provide a CSD registration report. A valid SARS Tax Clearance Pin is required. A valid CIPC registration certificate is required. Bidders must hold a valid licence to manufacture or import (in the name of the bidder) including all annexures. Bidders must hold a valid licence to manufacture/import distribute/wholesale Complementary Medicines (in the name of the bidder) including annexures and DA02 product list. Bidders must hold a valid licence to manufacture/import distribute/wholesale a medical device or IVD (in the name of the bidder) including annexures. Valid Medicine Registration Certificates (MRC) for each product offered are required. A valid B-BBEE certificate (SANAS accredited) or sworn affidavit (EME/QSE) where applicable is required. SBD4 (Declaration of Interest) and SBD6.1 (Preference Points Claim) must be completed. SBD5 (National Industrial Participation Programme) must be completed. PBD11 (Declaration of Financial Solvency and Business Rescue Status) must be completed. PBD5 (GMP Declaration of Compliance) and PBD8 (SRCC and GCC Declaration of Compliance) must be completed. The Excel Bid Response (Pricing Schedule) must be signed; if not, the bid will not be considered for evaluation. All mandatory documents must be submitted in the exact order listed; failure to do so may affect evaluation.

The tender is for the supply and delivery of small biological preparations to the Department of Health over a three-year period from 01 January 2028 to 31 December 2030. The scope includes 44 line items covering blood products, immunoglobulins, recombinant factors, and vaccines, each with estimated quantities and specific specifications.

Returnable documents: the bid response spreadsheet (HP10-2028BIO_Bid Response) must be completed in full, including all pricing fields, product registration numbers, licence details, lead times, batch capacity, barcode/NAPPI codes, distributor and manufacturer details, API sources, and local content percentages. If any listed manufacturer or third party is involved, PBD1 must be completed. Prices must be in ZAR with two decimals and may not exceed the SEP (current listing corresponding unit).

Bidders must be registered on the Central Supplier Database (CSD). Products must have a valid Product Registration Number and the bidder must hold a valid License to Manufacture Medicines (or be an authorised distributor). Bidders must meet lead times (≤14 calendar days delivery, ≤75 calendar days initial) and have sufficient monthly batch capacity. Local content requirements apply per SBD 6.2 (Declaration for Local Production and Content). SBD 9 (Certificate of Independent Bid Determination) certifies no collusive practices.

The tender covers 44 items of small biological preparations, including: albumin human 20% (50ml and 100ml), botulinum toxin type A 100 iu/vial, emicizumab injections (30mg, 60mg, 105mg, 150mg) with parenteral administration kits (items 4-9 considered as a series), activated prothrombin complex concentrate (500 iu and 1000 iu), factor VIII complex (300, 500, 1000 IU), factor IX complex 500 iu, various immunoglobulins (anti-D, anti-rabies, hepatitis B, normal IM 2ml/5ml, normal IV 1g/3g/6g/12g, tetanus, varicella zoster), lyophilised plasma (50ml and 200ml), recombinant factor VIIa (1mg, 2mg, 5mg), recombinant antihaemophilic factor VIII (250, 500, 1000 iu), and vaccines (hepatitis B, influenza, meningococcal conjugate, pneumococcal conjugate 13-valent, pneumococcal polysaccharide 23-valent, rabies, yellow fever, tetanus toxoid, varicella-zoster). Items 41 and 42 (yellow fever vaccine and cards) are considered as a series. Each item has an estimated quantity for the full tender period (01 January 2028 to 31 December 2030).

Delivered prices must be quoted in ZAR with two decimals, per unit and per shipper pack. Prices may not exceed the SEP (current listing corresponding unit). The bid response includes fields for % of delivered price attributable to API, formulation, packaging, logistics, and gross margin, with local vs imported breakdowns.

CSD registration required. Valid License to Manufacture Medicines (licence number and expiry date) required. Valid Product Registration Number for each product. Conformance to specification must be declared (Y/N); deviations must be detailed. Local content declaration per SBD 6.2. Independent bid determination per SBD 9. If any manufacturer or third party is involved, PBD1 must be completed.

The tender is for the supply and delivery of small biological preparations to the Department of Health for the period 01 January 2028 to 31 December 2030.

The tender document includes a PBD 4.1 form for capturing contact details for contract enquiries, orders, and the National Key Account Manager or Tender Manager, but no specific names, emails, or phone numbers are provided in the extracted text.

Bidders must complete and submit PBD 4.1 (Bidder Contact Details) along with SBD 1 (Invitation to Bid) as the offer cover page. The form requires the registered legal name as on CSD, CSD number, vendor number, and contact details for contract enquiries, orders, and the tender manager.

Bidders must be registered on the Central Supplier Database (CSD) and provide their CSD number and vendor number. No further evaluation criteria are stated in the available document.

Bidders must be registered on the Central Supplier Database (CSD) and provide their CSD number and vendor number. No other compliance requirements are stated in the available document.